{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:24:55Z","timestamp":1769023495930,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1208\/s12249-021-02068-w","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T16:04:12Z","timestamp":1624896252000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development of Spray-Dried Cyclodextrin-Based Pediatric Anti-HIV Formulations"],"prefix":"10.1208","volume":"22","author":[{"given":"Ryan","family":"Ivone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashvin","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenton","family":"DeBoef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha A.","family":"Meenach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,28]]},"reference":[{"key":"2068_CR1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jconrel.2015.08.042","volume":"219","author":"AG Nelson","year":"2016","unstructured":"Nelson AG, Zhang X, Ganapathi U, Szekely Z, Charles W, Owen A, et al. HHS Public Access. J Control Release. 2016;219:669\u201380.","journal-title":"J Control Release"},{"key":"2068_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2217\/nnm.10.25","volume":"5","author":"R Mallipeddi","year":"2010","unstructured":"Mallipeddi R, Rohan LC. Progress in antiretroviral drug delivery using nanotechnology. Int J Nanomedicine. 2010;5:533\u201347.","journal-title":"Int J Nanomedicine"},{"key":"2068_CR3","first-page":"1","volume":"8","author":"AB Bhatti","year":"2016","unstructured":"Bhatti AB, Usman M, Kandi V. Current scenario of HIV\/AIDS, treatment options, and major challenges with compliance to antiretroviral therapy. Cureus. 2016;8:1\u201312.","journal-title":"Cureus."},{"key":"2068_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jconrel.2016.02.001","volume":"226","author":"K Pham","year":"2016","unstructured":"Pham K, Li D, Guo S, Penzak S, Dong X. Development and in vivo evaluation of child-friendly lopinavir\/ritonavir pediatric granules utilizing novel in situ self-assembly nanoparticles. J Control Release. 2016;226:88\u201397.","journal-title":"J Control Release"},{"key":"2068_CR5","doi-asserted-by":"publisher","first-page":"1654938","DOI":"10.1155\/2016\/1654938","volume":"2016","author":"AF Schlatter","year":"2016","unstructured":"Schlatter AF, Deathe AR, Vreeman RC. The need for pediatric formulations to treat children with HIV. AIDS Research and Treatment. 2016;2016:1654938.","journal-title":"AIDS Research and Treatment"},{"key":"2068_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1542\/peds.2013-3225","volume":"134","author":"V Ivanovska","year":"2014","unstructured":"Ivanovska V, Rademaker CMA, Van Dijk L, Mantel-Teeuwisse AK. Pediatric drug formulations: a review of challenges and progress. Pediatrics. 2014;134:361\u201372.","journal-title":"Pediatrics."},{"key":"2068_CR7","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.2147\/TCRM.S3285","volume":"4","author":"A Chandwani","year":"2008","unstructured":"Chandwani A. Shuter J (2008) Lopinavir \/ ritonavir in the treatment of HIV-1 infection: a review. Ther Clin Risk Manag. 2008;4:1023\u201333.","journal-title":"Ther Clin Risk Manag"},{"key":"2068_CR8","unstructured":"Best Pharmaceutical\u2019s for Children Act (BPCA). https:\/\/www.nichd.nih.gov\/research\/supported\/bpca"},{"key":"2068_CR9","doi-asserted-by":"crossref","unstructured":"Pittman DW, Brantly AM, Drobonick AL, King HT, Mesta DC, Richards CG, et al. The palatability of lopinavir and ritonavir delivered by an innovative freeze-dried fast-dissolving tablet formulation. AIDS Research and Treatment. 2018;5908167.","DOI":"10.1155\/2018\/5908167"},{"key":"2068_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules23051161","volume":"23","author":"P Saokham","year":"2018","unstructured":"Saokham P, Muankaew C, Jansook P, Loftsson T. Solubility of cyclodextrins and drug\/cyclodextrin complexes. Molecules. 2018;23:1\u201315.","journal-title":"Molecules."},{"key":"2068_CR11","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1039\/C7RA11015D","volume":"8","author":"SK Chay","year":"2018","unstructured":"Chay SK, Keating AV, James C, Aliev AE, Haider S, Craig DQM. Evaluation of the taste-masking effects of (2-hydroxypropyl)-\u03b2-cyclodextrin on ranitidine hydrochloride: a combined biosensor, spectroscopic and molecular modelling assessment. RSC Adv. 2018;8:3564\u201373.","journal-title":"RSC Adv"},{"key":"2068_CR12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10847-006-9247-2","volume":"57","author":"T Loftsson","year":"2007","unstructured":"Loftsson T, Hreinsd\u00f3ttir D, M\u00e1sson M. The complexation efficiency. J Incl Phenom Macrocycl Chem. 2007;57:545\u201352.","journal-title":"J Incl Phenom Macrocycl Chem"},{"key":"2068_CR13","doi-asserted-by":"publisher","first-page":"12792","DOI":"10.1039\/C6CC03888C","volume":"52","author":"D Brynn Hibbert","year":"2016","unstructured":"Brynn Hibbert D, Thordarson P. The death of the Job plot, transparency, open science and online tools, uncertainty estimation methods and other developments in supramolecular chemistry data analysis. Chem Commun. 2016;52:12792\u2013805.","journal-title":"Chem Commun"},{"key":"2068_CR14","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1039\/C0CS00062K","volume":"40","author":"P Thordarson","year":"2011","unstructured":"Thordarson P. Determining association constants from titration experiments in supramolecular chemistry. Chem Soc Rev. 2011;40:1305\u201323.","journal-title":"Chem Soc Rev"},{"key":"2068_CR15","unstructured":"Molecular Operating Environment (MOE), 2019.01; Chemical Computing Group ULC, 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, 2021"},{"key":"2068_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10847-011-0022-7","volume":"73","author":"G Goyal","year":"2011","unstructured":"Goyal G, Vavia PR. Complexation approach for fixed dose tablet formulation of lopinavir and ritonavir: an anomalous relationship between stability constant, dissolution rate and saturation solubility. J Incl Phenom Macrocycl Chem. 2011;73:75\u201385.","journal-title":"J Incl Phenom Macrocycl Chem"},{"key":"2068_CR17","doi-asserted-by":"publisher","first-page":"115287","DOI":"10.1016\/j.carbpol.2019.115287","volume":"227","author":"O Adeoye","year":"2020","unstructured":"Adeoye O, Concei\u00e7\u00e3o J, Serra PA, Bento da Silva A, Duarte N, Guedes RC, et al. Cyclodextrin solubilization and complexation of antiretroviral drug lopinavir: in silico prediction: effects of derivatization, molar ratio and preparation method. Carbohydr Polym. 2020;227:115287.","journal-title":"Carbohydr Polym"},{"key":"2068_CR18","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0032-9592(03)00258-9","volume":"39","author":"EMM Del Valle","year":"2003","unstructured":"Del Valle EMM. Cyclodextrins and their uses: a review. Process Biochem. 2003;39:1033\u201346.","journal-title":"Process Biochem"},{"key":"2068_CR19","first-page":"155","volume":"2","author":"A Baykal","year":"2019","unstructured":"Baykal A, Bozkurt A, Jeremy R, Asiri SMM, Lima-Ten\u00f3rio MK, Kaewsaneha C, et al. Multistimuli-responsive magnetic assemblies. Advanced Nanocarriers for Therapeutics. 2019;2:155\u201393.","journal-title":"Advanced Nanocarriers for Therapeutics"},{"key":"2068_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-31373-x","volume":"8","author":"B Rajbanshi","year":"2018","unstructured":"Rajbanshi B, Saha S, Das K, Barman BK, Sengupta S, Bhattacharjee A, et al. Study to probe subsistence of host-guest inclusion complexes of \u03b1 and \u03b2-cyclodextrins with biologically potent drugs for safety regulatory dischargement. Sci Rep. 2018;8:1\u201320.","journal-title":"Sci Rep"},{"key":"2068_CR21","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1039\/C7CC01114H","volume":"53","author":"CL Wang","year":"2017","unstructured":"Wang CL, Zhou L, Zhang L, Xiang JF, Rambo BM, Sessler JL, et al. Discrete 1\u2009: 1 complexes and higher order assemblies formed from aminobenzene sulphonate anions and a tetraimidazolium \u201cmolecular box.\u201d. Chem Commun. 2017;53:3669\u201372.","journal-title":"Chem Commun"},{"key":"2068_CR22","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1208\/s12249-014-0269-6","volume":"16","author":"A Gryczke","year":"2015","unstructured":"Gryczke A, Langley N, Alshahrani SM, Park J-B, Alsulays BB, Majumdar S, et al. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus\u00ae and HPMCAS-HF. AAPS PharmSciTech. 2015;16:824\u201334.","journal-title":"AAPS PharmSciTech"},{"key":"2068_CR23","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1016\/j.xphs.2018.08.010","volume":"107","author":"NK Thakral","year":"2018","unstructured":"Thakral NK, Zanon RL, Kelly RC, Thakral S. Applications of powder X-ray diffraction in small molecule pharmaceuticals: achievements and aspirations. J Pharm Sci. 2018;107:2969\u201382.","journal-title":"J Pharm Sci"},{"key":"2068_CR24","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1002\/jps.24492","volume":"104","author":"S Sakuma","year":"2015","unstructured":"Sakuma S, Matsumoto S, Ishizuka N, Mohri K, Fukushima M, Ohba C, et al. Enhanced boosting of oral absorption of lopinavir through electrospray coencapsulation with ritonavir. J Pharm Sci. 2015;104:2977\u201385.","journal-title":"J Pharm Sci"},{"key":"2068_CR25","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1128\/AAC.44.4.1117-1118.2000","volume":"44","author":"K Gallicano","year":"2000","unstructured":"Gallicano K. Antiretroviral-drug concentrations in semen. Antimicrob Agents Chemother. 2000;44:1117\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"2068_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph12010015","volume":"12","author":"JF Alopaeus","year":"2019","unstructured":"Alopaeus JF, Hages\u00e6ther E, Tho I. Micellisation mechanism and behaviour of soluplus\u00ae\u2013furosemide micelles: preformulation studies of an oral nanocarrier-based system. Pharmaceuticals. 2019;12:1\u201323.","journal-title":"Pharmaceuticals."},{"key":"2068_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3390\/pharmaceutics10030098","volume":"10","author":"A Karagianni","year":"2018","unstructured":"Karagianni A, Kachrimanis K, Nikolakakis I. Co-amorphous solid dispersions for solubility and absorption improvement of drugs: composition, preparation, characterization and formulations for oral delivery. Pharmaceutics. 2018;10:98.","journal-title":"Pharmaceutics."}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-021-02068-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-021-02068-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-021-02068-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T17:24:12Z","timestamp":1627320252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-021-02068-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,28]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2068"],"URL":"https:\/\/doi.org\/10.1208\/s12249-021-02068-w","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,28]]},"assertion":[{"value":"8 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"193"}}